Detalhe da pesquisa
1.
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clin Gastroenterol Hepatol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604296
2.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol
; 22(4): 789-797.e8, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048934
3.
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis.
Expert Opin Emerg Drugs
; : 1-11, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469871
4.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661715
5.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol
; 21(2): 370-379, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051649
6.
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology
; 76(1): 186-195, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34951726
7.
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Liver Int
; 43(10): 2210-2219, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470077
8.
Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease.
Hepatol Res
; 53(3): 219-227, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378589
9.
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease.
Hepatol Res
; 53(10): 978-988, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353881
10.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(6): 489-496, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807720
11.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res
; 53(4): 312-321, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524984
12.
M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis.
Hepatol Res
; 53(9): 844-856, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237426
13.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(5): 391-400, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707103
14.
Real-world assessment of SmartExam, a novel FibroScan computational method: A retrospective single-center cohort study.
J Gastroenterol Hepatol
; 38(2): 321-329, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36436879
15.
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia study.
J Gastroenterol Hepatol
; 38(6): 896-904, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797989
16.
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning.
J Gastroenterol Hepatol
; 38(10): 1832-1839, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596843
17.
Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 20(4): 908-917.e11, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340780
18.
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia.
J Gastroenterol Hepatol
; 37(12): 2313-2320, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198983
19.
Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome.
Int J Mol Sci
; 23(19)2022 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232990
20.
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake.
Oncologist
; 26(10): e1862-e1869, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180099